Salvianolic acid B (Sal B) is a phenolic compound that shows promise in protecting against cerebral ischemia injury through its antioxidation and neuroprotective properties.
Recent research indicates that Sal B may also help prevent steroid-induced osteonecrosis of the femoral head by improving histopathological scores, inhibiting osteoclast differentiation, and promoting the osteogenesis of mesenchymal stem cells in rat models.
The treatment with Sal B affects specific proteins related to bone metabolism, suggesting it works by modulating PPARγ expression, which may provide a potential therapeutic approach for managing steroid-induced osteonecrosis.